Alzinova Year End Report

"2020 was an important year and, our goal-oriented work has ensured that we are well prepared for the start of our upcoming clinical study in 2021 in patients with Alzheimer’s disease, despite the challenges of the Covid-19 pandemic." Kristina Torfgård, CEO Alzinova AB. We have published our year-end report 2020. Read the full report here: